share_log

Enlighta Inc. Announces Resignation of Director and President

Enlighta Inc. Announces Resignation of Director and President

Enlighta 公司宣佈董事兼總裁辭職
Accesswire ·  09/26 13:00

RICHMOND, BC / ACCESSWIRE / September 26, 2024 / Enlighta Inc. (NEX:NLTA.H) announces today that Norman Tsui, a founder and President and long-time director of the company, has resigned from his position effective immediately. Norman has been with Enlighta since its inception in 2010 and played a pivotal role in the company's initial foundations, including the financing, development of its early technology, and the successful public listing on the TSX Venture Exchange.

不列顛哥倫比亞省里士滿/ACCESSWIRE/2024年9月26日/Enlighta Inc.(NEX: NLTA.H)今天宣佈,公司創始人、總裁兼長期董事徐諾曼已辭職,立即生效。自2010年Enlighta成立以來,Norman一直在Enlighta工作,並在公司的初始基礎上發揮了關鍵作用,包括融資、早期技術的開發以及在多倫多證券交易所風險交易所的成功公開上市。

Norman's leadership and dedication over the years have been instrumental in establishing Enlighta as an early mover in stem cell isolation technologies. For personal reasons, Norman has chosen to step down from his role but remains supportive in Enlighta's evolution. He has graciously offered to make himself available during the transition as a consultant, ensuring a smooth handover of responsibilities.

多年來,諾曼的領導能力和奉獻精神在確立Enlighta成爲幹細胞分離技術的先行者方面發揮了重要作用。出於個人原因,諾曼選擇辭職,但仍然支持Enlighta的發展。他慷慨地表示願意在過渡期間擔任顧問,確保順利移交責任。

The Board of Directors extends its heartfelt thanks to Norman for his years of dedicated service and wishes him all the best in his future endeavors. His visionary leadership and unwavering commitment will be greatly missed.

董事會衷心感謝諾曼多年的奉獻服務,並祝願他在未來的工作中一切順利。人們將非常懷念他富有遠見的領導能力和堅定不移的承諾。

About Enlighta Inc.

關於 Enlighta Inc.

Enlighta Inc. is a diversified technology company developing global strategic partnerships and in licensing of technologies and assets for rapid growth and high value solutions. Additional details with respect to the Company are available on SEDAR ()

Enlighta Inc. 是一家多元化科技公司,致力於發展全球戰略合作伙伴關係,爲快速增長和高價值解決方案提供技術和資產許可。有關該公司的其他詳細信息可在SEDAR () 上找到

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Forward Looking Statements:

前瞻性陳述:

Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of Enlighta. This information and these statements, referred to herein as "forwardlooking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to the agreements with Enlighta. These statements generally can be identified by use of forward-looking terms such as "may", "will", "expect", "estimate", "anticipate", "intends", "believe" or "continue" or the negative thereof or similar variations. These forwardlooking statements involve numerous risks and uncertainties and actual results might differ materially from results anticipated in any forward-looking statements. Enlighta does not assume any obligation to update the forward- looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements, other than as required by applicable securities laws.

前瞻性陳述與未來事件或未來業績有關,反映了對Enlighta管理層未來事件的期望或信念。這些信息和這些陳述(此處稱爲 「前瞻性陳述」)不是歷史事實,是截至本新聞發佈之日發佈的,包括但不限於有關未來計劃、估計和預測討論的聲明,以及關於管理層對與Enlighta協議的預期和意圖的陳述。這些陳述通常可以通過使用諸如 「可能」、「將」、「期望」、「估計」、「預期」、「打算」、「打算」、「相信」 或 「繼續」 等前瞻性術語來識別,或者其否定或類似的變體。這些前瞻性陳述涉及許多風險和不確定性,實際結果可能與任何前瞻性陳述中的預期結果存在重大差異。除非適用的證券法要求,否則Enlighta不承擔任何更新前瞻性陳述的義務,也沒有義務更新實際業績可能與前瞻性陳述中反映的結果不同的原因。

For further information, please contact:

欲了解更多信息,請聯繫:

Avis Zhu, CEO and Director
Enlighta Inc. (604) 200-8028

Avis Zhu,首席執行官兼董事
Enlighta Inc. (604) 200-8028

SOURCE: Enlighta Inc.

來源:Enlighta Inc.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論